End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.25 TWD | +0.12% | -0.24% | -12.71% |
May. 06 | Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
TWD in Million | 2023 | Weight | Delta |
---|---|---|---|
Biomedical
103.6
%
| 645 | 103.6 % | - |
Adjustments and Write-offs
-6.9
%
| -43 | -6.9 % | - |
Consumer
3.3
%
| 20 | 3.3 % | - |
Sales per region
TWD in Million | 2023 | Weight | Delta |
---|---|---|---|
Taiwan
44.3
%
| 276 | 44.3 % | - |
America
32.0
%
| 199 | 32.0 % | - |
Asia
15.4
%
| 96 | 15.4 % | - |
Europe
4.5
%
| 28 | 4.5 % | - |
Other
3.8
%
| 24 | 3.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jing Ting Chen
CEO | Chief Executive Officer | - | 21-11-02 |
Ruei Yi Wu
DFI | Director of Finance/CFO | - | 23-03-21 |
Yi Hua Yu
DFI | Director of Finance/CFO | - | 18-06-20 |
Cian Tian Huang
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yong Xiang Lin
CHM | Chairman | - | 21-07-11 |
Xiu Yuan Li
BRD | Director/Board Member | - | 15-06-21 |
Zhen Zhen Fu
BRD | Director/Board Member | - | 21-07-11 |
Jing Ting Chen
CEO | Chief Executive Officer | - | 21-11-02 |
Song Yuan Liao
BRD | Director/Board Member | - | 21-07-11 |
Shih Ming Li
BRD | Director/Board Member | - | 21-07-11 |
Zhong Ming Zeng
BRD | Director/Board Member | - | 21-07-11 |
Tsong Jieh Chiou
BRD | Director/Board Member | - | 22-06-20 |
Shih Ming Lai
BRD | Director/Board Member | - | 22-06-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 88,957,115 | 49,177,115 ( 55.28 %) | 0 | 55.28 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-12.71% | 116M | |
+0.32% | 262B | |
+18.76% | 20.37B | |
-.--% | 19.29B | |
+16.91% | 12.64B | |
-16.59% | 8.94B | |
+33.93% | 8.62B | |
+9.55% | 5.93B | |
-12.08% | 3.92B | |
-16.83% | 3.84B |
- Stock Market
- Equities
- 1783 Stock
- Company Maxigen Biotech Inc.